<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ru">
	<id>https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=STX16</id>
	<title>STX16 - История изменений</title>
	<link rel="self" type="application/atom+xml" href="https://transhumanist.ru/index.php?action=history&amp;feed=atom&amp;title=STX16"/>
	<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=STX16&amp;action=history"/>
	<updated>2026-04-11T22:55:17Z</updated>
	<subtitle>История изменений этой страницы в вики</subtitle>
	<generator>MediaWiki 1.43.6</generator>
	<entry>
		<id>https://transhumanist.ru/index.php?title=STX16&amp;diff=4476&amp;oldid=prev</id>
		<title>OdysseusBot: Новая страница: «Syntaxin-16 (Syn16)  ==Publications==  {{medline-entry |title=Clinical characterization and molecular classification of 12 Korean patients with pseudohypoparathyr...»</title>
		<link rel="alternate" type="text/html" href="https://transhumanist.ru/index.php?title=STX16&amp;diff=4476&amp;oldid=prev"/>
		<updated>2021-04-29T19:20:00Z</updated>

		<summary type="html">&lt;p&gt;Новая страница: «Syntaxin-16 (Syn16)  ==Publications==  {{medline-entry |title=Clinical characterization and molecular classification of 12 Korean patients with pseudohypoparathyr...»&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Новая страница&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Syntaxin-16 (Syn16)&lt;br /&gt;
&lt;br /&gt;
==Publications==&lt;br /&gt;
&lt;br /&gt;
{{medline-entry&lt;br /&gt;
|title=Clinical characterization and molecular classification of 12 Korean patients with pseudohypoparathyroidism and pseudopseudohypoparathyroidism.&lt;br /&gt;
|pubmed-url=https://pubmed.ncbi.nlm.nih.gov/24127307&lt;br /&gt;
|abstract=Pseudohypoparathyroidism (PHP) is defined as resistance toward parathyroid hormones. PHP and pseudopseudohypoparathyroidism (PPHP) are rare disorders resulting from genetic and epigenetic aberrations within or upstream of the [[[[[[[[GNAS]]]]]]]] locus. This study investigated the clinical characteristics and performed a molecular analysis of PHP and PPHP. A total of 12 patients with (P)PHP from 11 unrelated families (4 with PHP-Ia, 6 with PHP-Ib, and 2 with PPHP) were characterized using both clinical and molecular methods. Clinical features included the presenting symptoms, Albright hereditary osteodystrophy features, and resistance to hormones. Comprehensive analysis of the [[[[[[[[GNAS]]]]]]]] and [[STX16]] loci was undertaken to investigate the molecular defects underlying (P)PHP. All PHP-Ib patients displayed hypocalcemic symptoms. All PHP-Ia patients showed resistance toward TSH, in addition to [[PTH]]. In most patients with PHP, when the diagnosis of PHP was first established, hypocalcemia and hyperphosphatemia were associated with a significant increase in serum [[PTH]] levels. One patient with PHP-Ia was diagnosed with growth hormone deficiency and showed a good response to human recombinant growth hormone therapy. 6 patients with PHP-Ia and PPHP showed 5 different mutations in the [[[[[[[[GNAS]]]]]]]] gene. 5 patients with PHP-Ib displayed a loss of differentially methylated region (DMR) imprints of the maternal [[[[[[[[GNAS]]]]]]]]. One PHP-Ib patient showed a de novo microdeletion in [[STX16]] and a loss of methylation of exon A/B on the maternal allele. No patients revealed paternal disomy among 4 patients with PHP-Ib. Identification of the molecular causes of PHP and PPHP explains their distinctive clinical features and enables confirmation of the diagnosis and exact genetic counseling.&lt;br /&gt;
|mesh-terms=* Adult&lt;br /&gt;
* Aging&lt;br /&gt;
* Asian Continental Ancestry Group&lt;br /&gt;
* Child&lt;br /&gt;
* Child, Preschool&lt;br /&gt;
* Chromogranins&lt;br /&gt;
* DNA&lt;br /&gt;
* DNA Methylation&lt;br /&gt;
* DNA Mutational Analysis&lt;br /&gt;
* Exons&lt;br /&gt;
* Female&lt;br /&gt;
* GTP-Binding Protein alpha Subunits, Gs&lt;br /&gt;
* Gene Deletion&lt;br /&gt;
* Growth&lt;br /&gt;
* Humans&lt;br /&gt;
* Male&lt;br /&gt;
* Microsatellite Repeats&lt;br /&gt;
* Polymerase Chain Reaction&lt;br /&gt;
* Pseudohypoparathyroidism&lt;br /&gt;
* Pseudopseudohypoparathyroidism&lt;br /&gt;
* Syntaxin 16&lt;br /&gt;
&lt;br /&gt;
|full-text-url=https://sci-hub.do/10.1055/s-0033-1349867&lt;br /&gt;
}}&lt;/div&gt;</summary>
		<author><name>OdysseusBot</name></author>
	</entry>
</feed>